Prospective Cohort Real-World Study on Neuroendocrine Tumor Patient's Quality of Life During Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE
Conclusions
177Lu-DOTATATE therapy improved global health and reduced disease-related symptoms in NET patients, positively impacting health-related quality of life.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Gastroenterology | Neurology | Pancreas | Pancreatic Cancer | Students | Study | Universities & Medical Training